[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212 220 6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 36, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 997010, "exercisedValue": 0, "unexercisedValue": 164999}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 54, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 638607, "exercisedValue": 0, "unexercisedValue": 51561}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 45, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 703319, "exercisedValue": 0, "unexercisedValue": 61875}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 68, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 309621, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Brandi L. Roberts CPA, M.B.A.", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Mack", "title": "Senior Vice President of Pharmaceutical Development & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Calitri", "title": "Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Fagan", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregg  Pratt Ph.D.", "title": "Chief Regulatory & Quality Assurance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.87, "open": 14.86, "dayLow": 14.31, "dayHigh": 15.16, "regularMarketPreviousClose": 14.87, "regularMarketOpen": 14.86, "regularMarketDayLow": 14.31, "regularMarketDayHigh": 15.16, "payoutRatio": 0.0, "beta": 2.621, "forwardPE": -8.471518, "volume": 2042821, "regularMarketVolume": 2042821, "averageVolume": 2118447, "averageVolume10days": 2325935, "averageDailyVolume10Day": 2325935, "bid": 8.98, "ask": 15.52, "bidSize": 2, "askSize": 2, "marketCap": 1460232320, "fiftyTwoWeekLow": 4.7, "fiftyTwoWeekHigh": 18.12, "allTimeHigh": 86.549995, "allTimeLow": 1.249499, "fiftyDayAverage": 13.4802, "twoHundredDayAverage": 10.2896, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1311524352, "profitMargins": 0.0, "floatShares": 97564575, "sharesOutstanding": 97219193, "sharesShort": 15054621, "sharesShortPriorMonth": 12350292, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.1528, "heldPercentInsiders": 0.0059399996, "heldPercentInstitutions": 0.41647, "shortRatio": 7.82, "shortPercentOfFloat": 0.1537, "impliedSharesOutstanding": 97219193, "bookValue": 1.701, "priceToBook": 8.8301, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -168098000, "trailingEps": -1.98, "forwardEps": -1.773, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "enterpriseToEbitda": -8.647, "52WeekChange": 1.3879781, "SandP52WeekChange": 0.14272952, "quoteType": "EQUITY", "currentPrice": 15.02, "targetHighPrice": 61.0, "targetLowPrice": 16.0, "targetMeanPrice": 28.66667, "targetMedianPrice": 24.5, "recommendationMean": 1.23077, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 209070000, "totalCashPerShare": 2.122, "ebitda": -151672752, "totalDebt": 40985000, "quickRatio": 3.196, "currentRatio": 3.3, "debtToEquity": 31.383, "returnOnAssets": -0.33949003, "returnOnEquity": -0.85592, "freeCashflow": -47703376, "operatingCashflow": -113936000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.00875, "regularMarketPrice": 15.02, "marketState": "CLOSED", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "exchange": "NMS", "messageBoardId": "finmb_631045282", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [{"header": "Ticker Change", "message": "MNMD is trading under new symbol DFTX effective Jan. 15, 2026", "meta": {"eventType": "TICKER_CHANGE", "dateEpochMs": 1768453200000, "newTicker": "DFTX"}}], "regularMarketTime": 1768424401, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1583332200000, "regularMarketChange": 0.150001, "regularMarketDayRange": "14.31 - 15.16", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2118447, "fiftyTwoWeekLowChange": 10.320001, "fiftyTwoWeekLowChangePercent": 2.195745, "fiftyTwoWeekRange": "4.7 - 18.12", "fiftyTwoWeekHighChange": -3.1000004, "fiftyTwoWeekHighChangePercent": -0.17108169, "fiftyTwoWeekChangePercent": 138.7978, "dividendDate": 1582761600, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.98, "epsForward": -1.773, "epsCurrentYear": -2.01, "priceEpsCurrentYear": -7.472637, "fiftyDayAverageChange": 1.5398006, "fiftyDayAverageChangePercent": 0.11422684, "twoHundredDayAverageChange": 4.7304, "twoHundredDayAverageChangePercent": 0.4597263, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-27", "averageAnalystRating": "1.2 - Strong Buy", "displayName": "Mind Medicine (MindMed)", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]